Mar 08, 2019 / 09:30PM GMT
Operator
Welcome to the Conatus Pharmaceuticals' financial results conference call. (Operator Instructions) This call is being webcast live on the investor center of the Conatus website at conatuspharma.com. This call is property of Conatus Pharmaceuticals, and recordings, reproduction or transmission of this call without the expressed written consent of Conatus is strictly prohibited. As a reminder, today's call is being recorded.
I would now like to introduce Alan Engbring, Executive Director of Investor Relations and Corporate Communications at Conatus. Sir?
Alan R. Engbring - Conatus Pharmaceuticals Inc. - Executive Director of IR & Corporate Communications
Good afternoon. A press release with the company's fourth quarter 2018 financial results was issued earlier this afternoon and can be found in the Investor section of the Conatus website at conatuspharma.com.
During today's call, we may make forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Actual results could differ materially from those
Q4 2018 Conatus Pharmaceuticals Inc Earnings Call Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers